137 related articles for article (PubMed ID: 32362194)
21. Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout.
Ali Z; Din FU; Zahid F; Sohail S; Imran B; Khan S; Malik M; Zeb A; Khan GM
BMC Pharmacol Toxicol; 2022 Nov; 23(1):86. PubMed ID: 36443818
[TBL] [Abstract][Full Text] [Related]
22. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy:
Abd-Elhakeem E; El-Nabarawi M; Shamma R
Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445
[TBL] [Abstract][Full Text] [Related]
23. Formulation design and optimization of cationic-charged liposomes of brimonidine tartrate for effective ocular drug delivery by design of experiment (DoE) approach.
Soni PK; Saini TR
Drug Dev Ind Pharm; 2021 Nov; 47(11):1847-1866. PubMed ID: 35484943
[TBL] [Abstract][Full Text] [Related]
24. Proniosomal gel-mediated topical delivery of fluconazole: Development,
Abu El-Enin ASM; Khalifa MKA; Dawaba AM; Dawaba HM
J Adv Pharm Technol Res; 2019; 10(1):20-26. PubMed ID: 30815384
[TBL] [Abstract][Full Text] [Related]
25. Nano-transfersomal formulations for transdermal delivery of asenapine maleate: in vitro and in vivo performance evaluations.
Shreya AB; Managuli RS; Menon J; Kondapalli L; Hegde AR; Avadhani K; Shetty PK; Amirthalingam M; Kalthur G; Mutalik S
J Liposome Res; 2016 Sep; 26(3):221-32. PubMed ID: 26621370
[TBL] [Abstract][Full Text] [Related]
26. Nanosized ethosomal dispersions for enhanced transdermal delivery of nebivolol using intradermal/transfollicular sustained reservoir:
Fouad SA; Khatab ST; Teaima MH; El-Nabarawi MA; Abdelmonem R
Pharm Dev Technol; 2024 Jan; 29(1):40-51. PubMed ID: 38078863
[TBL] [Abstract][Full Text] [Related]
27. Systematically Optimized Ketoprofen-Loaded Novel Proniosomal Formulation for Periodontitis: In Vitro Characterization and In Vivo Pharmacodynamic Evaluation.
Yadav NK; Nanda S; Sharma G; Katare OP
AAPS PharmSciTech; 2017 Jul; 18(5):1863-1880. PubMed ID: 27844417
[TBL] [Abstract][Full Text] [Related]
28. A novel vesicular transdermal delivery of nifedipine - preparation, characterization and in vitro/in-vivo evaluation.
Yasam VR; Jakki SL; Natarajan J; Venkatachalam S; Kuppusamy G; Sood S; Jain K
Drug Deliv; 2016; 23(2):619-30. PubMed ID: 25005581
[TBL] [Abstract][Full Text] [Related]
29. Oro-dental mucoadhesive proniosomal gel formulation loaded with lornoxicam for management of dental pain.
Abdelbary GA; Aburahma MH
J Liposome Res; 2015; 25(2):107-21. PubMed ID: 25058447
[TBL] [Abstract][Full Text] [Related]
30. Transethosomes of Econazole Nitrate for Transdermal Delivery: Development, In-vitro Characterization, and Ex-vivo Assessment.
Verma S; Utreja P
Pharm Nanotechnol; 2018; 6(3):171-179. PubMed ID: 30101725
[TBL] [Abstract][Full Text] [Related]
31. Formulation and evaluation of the topical ethosomal gel of melatonin to prevent UV radiation.
Shukla R; Tiwari G; Tiwari R; Rai AK
J Cosmet Dermatol; 2020 Aug; 19(8):2093-2104. PubMed ID: 31829513
[TBL] [Abstract][Full Text] [Related]
32. Fabrication of Ethosomes Containing Tocopherol Acetate to Enhance Transdermal Permeation: In Vitro and Ex Vivo Characterizations.
Akhtar N; Akhtar N; Menaa F; Alharbi W; Alaryani FSS; Alqahtani AM; Ahmad F
Gels; 2022 May; 8(6):. PubMed ID: 35735679
[TBL] [Abstract][Full Text] [Related]
33. Transdermal delivery of oxybutynin chloride proniosomal gels for the treatment of overactive bladder.
Rajabalaya R; David SR; Chellian J; Xin Yun G; Chakravarthi S
Drug Deliv; 2016 Jun; 23(5):1578-87. PubMed ID: 26634274
[TBL] [Abstract][Full Text] [Related]
34. Fabrication and Appraisal of Simvastatin via Tailored Niosomal Nanovesicles for Transdermal Delivery Enhancement: In Vitro and In Vivo Assessment.
Salem HF; Kharshoum RM; Abou-Taleb HA; Farouk HO; Zaki RM
Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33494472
[TBL] [Abstract][Full Text] [Related]
35. Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies.
Abdelbary GA; Amin MM; Zakaria MY
Drug Deliv; 2017 Nov; 24(1):309-319. PubMed ID: 28165809
[TBL] [Abstract][Full Text] [Related]
36. Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation.
Thakur R; Anwer MK; Shams MS; Ali A; Khar RK; Shakeel F; Taha EI
J Drug Target; 2009 Jul; 17(6):442-9. PubMed ID: 19527115
[TBL] [Abstract][Full Text] [Related]
37. Formulation of Glibenclamide proniosomes for oral administration: Pharmaceutical and pharmacodynamics evaluation.
Alshora D; Ibrahim M; Alanazi N; Alowyid M; Ali Alnakhli Z; Mohammed Alshiban N; Maodaa S; Alyami NM; Alotaibi I
Saudi Pharm J; 2023 Dec; 31(12):101830. PubMed ID: 38028219
[TBL] [Abstract][Full Text] [Related]
38. Fabrication and Evaluation of Voriconazole Loaded Transethosomal Gel for Enhanced Antifungal and Antileishmanial Activity.
Farooq M; Usman F; Zaib S; Shah HS; Jamil QA; Akbar Sheikh F; Khan A; Rabea S; Hagras SAA; El-Saber Batiha G; Khan I
Molecules; 2022 May; 27(10):. PubMed ID: 35630825
[TBL] [Abstract][Full Text] [Related]
39. Nanostructured Etodolac Carriers in Transdermal Gel: Optimization and Characterization.
Patil P; Shirkhedkar A
Pharm Nanotechnol; 2023 Jun; 11(3):276-293. PubMed ID: 36635925
[TBL] [Abstract][Full Text] [Related]
40. Development and Optimization of Proniosomal Formulation of Irbesartan Using a Box-Behnken Design to Enhance Oral Bioavailability: Physicochemical Characterization and
Mujtaba MA; Kaleem M; Chaware R; Ingole A; Asiri YI; Hassan MZ; Sabale V; Sabale P; Anwer MK; Mahmood D; Aldawsari MF
ACS Omega; 2024 Apr; 9(14):16346-16357. PubMed ID: 38617636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
